Getting Started
Help your patients access GIVLAARI® (givosiran) with Alnylam Assist®
To make the process convenient for your patient, Alnylam Assist® provides 3 separate options
for initiating and completing the Start Form.

Downloadable Start Form
Print, complete with your patient, then fax the Start Form to 1-833-256-2747
OR

DocuSign Start Form
Begin the Start Form, then send to your patient via email to complete their portion
See DocuSign Instructions
What happens next:

Your patient's dedicated Case Manager will reach out to you and your patient within 1-2 business days of receiving a completed Start Form

The Alnylam Assist® team will facilitate acquisition of GIVLAARI for your patient via specialty distributor or specialty pharmacy
Alnylam Assist® provides personalized support for your patients throughout the treatment process

A dedicated Case Manager
Alnylam Assist® will connect patients with a dedicated Alnylam Case Manager who can provide personalized support throughout the GIVLAARI treatment process.

Disease and product education
Patient Education Liaisons (PELs) are available to help educate patients and their families on acute hepatic porphyria.

Benefit verification
Coverage for GIVLAARI will vary by plan and by patient. Alnylam Assist® can help determine patient-specific coverage requirements.

Financial assistance
Eligible patients* may qualify for the Alnylam Assist® Quick Start Program, Patient Assistance Program (PAP), or Commercial Copay Program.

Reimbursement education
Field Reimbursement Directors (FRDs) can help provide education about the GIVLAARI reimbursement process, including the process for prior authorizations, claims, and appeals. They can also help explain billing and coding, chart documentation, and payer requirements for GIVLAARI.

Monday–Friday, 8AM–6PM ET
: 1-833-256-2748 |
: 1-833-256-2747
*Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue the program at any time.